BloombergBiogen Says Tysabri Patient With Brain Illness Died By Elizabeth Lopatto
Dec. 19 (Bloomberg) -- A multiple sclerosis patient who developed a severe brain infection after taking Biogen Idec Inc. and Elan Corp.’s Tysabri,
the fourth case reported in five months, has died, according to Biogen.
Cambridge, Massachusetts-based Biogen was informed of the American woman’s death two days ago, company spokeswoman Naomi Aoki said in an interview.
The company reported on Oct. 29 that the patient had been diagnosed with the brain illness,
progressive multifocal leukoencephalopathy (PML).
Comments and/or Questions are always appreciated.. ============================================
Biogen Says Tysabri Patient With Brain Illness Died
By Elizabeth Lopatto
Dec. 19 (Bloomberg) -- A multiple sclerosis patient who developed a severe brain infection after taking Biogen Idec Inc. and Elan Corp.’s Tysabri, the fourth case reported in five months, has died, according to Biogen.
Cambridge, Massachusetts-based Biogen was informed of the American woman’s death two days ago, company spokeswoman Naomi Aoki said in an interview.
The company reported on Oct. 29 that the patient had been diagnosed with the brain illness, progressive multifocal leukoencephalopathy (PML).
Comments and/or Questions are always appreciated..
============================================